Katarzyna Kolasa has more than 16 years of working experience in the healthcare sector, with 10 years with the pharmaceutical and medical devices industry and six with the public payer. In the past, she worked at both global and regional HEOR functions at AstraZeneca and BiogenIdec being based in Sweden and Switzerland respectively. At Bristol Myers Squibb and Lunbeck she was leading Market Access teams in CEE and Nordic Region. Her practical skills in the field of health economics were developed during six years employment contract at the Kalmar County Council in Sweden. Since 2015, she has been working with pricing &reimbursement challenges in the field of medical devices. Currently being Global Market Access Principal Consultant for Straub Medical. Before that, Katarzyna was a Senior HEOR Director at GE Healthcare.

Health Economics

Carl Asche is the Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria, where he is a Research Professor both in the Departments of Medicine (Peoria) and Pharmacy Systems, Outcomes & Policy (Chicago). He is also a research affiliate with the University of Victoria Centre on Aging. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of being the author or co-author of over 75 papers appearing in the medical and economic literature. He is the editor of the forthcoming book entitled, “Applying Comparative Effectiveness Data to Medical Decision Making: A Practical Guide” (Adis, 2015). He has presented his research at seminars and conferences both nationally and internationally. He has served on numerous national and international health economics focused editorial, grant review, advisory boards and committees.Asche’s research is funded by a variety of state/federal agencies and health system providers.

Professor Khalid’s is a clinical cardiologist by training, Professor Khalid previously served as the Dean of Universiti Teknologi MARA’s Faculty of Medicine. Under his stewardship, the faculty recorded tremendous growth and established itself as one of the foremost medical faculties in the nation. Prior to that, Professor Khalid played a number of key roles – including serving as Dean – in a career spanning two decades at Universiti Kebangsaan Malaysia. He also served as a consultant cardiologist at both universities where he was instrumental in developing the Heart Centres at these universities. Professor Khalid began his medical career as a student at The University of Melbourne, Australia. He was then trained in Cardiology at the University of Newcastle-upon-Tyne, UK. On returning to Malaysia, he built a strong career in academia, bolstered by national and international recognition of his contributions. He is a firm advocate of research and development and his findings are frequently published in high-impact international journals. His papers are cited and referred to by many of his peers, adding credence to his standing as an academic. What Professor Khalid brings to UCSI further enhances the University’s strong links with the industry and its vibrant student life. The latest addition to Professor Khalid’s ever expanding list of accolades and awards is a Doctor of Medical Sciences (honoris causa) conferred by his alma mater, The University of Melbourne, Australia in October 2014. The citation for the honorary doctorate by the Melbourne University’s Council identifies him as a person of distinguished eminence in medical science, research and effective medical education. His international outlook was best demonstrated in his development and forging of strategic partnerships between UCSI and world leading universities, culminating in UCSI’s proudest moment when our top Year 2 medical student was selected for an intercalated research year at Harvard University in the USA

Dr. Teckle is a Health Economist at the Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency and an Assistant Professor in the School of Population and Public Health at the University of British Columbia. Previously he held positions at Health Economics Research Unit, University of Aberdeen UK. Whilst at the University of Aberdeen, Dr. Teckle was part of a research team that was commissioned by the Scottish Executive Health Department in 2005 to improve and refine the Arbuthnott Resources Allocation Formula used in Scotland. Since he joined the ARCC in 2006, Dr. Teckle has been working as a co-investigator in three projects: “Health-related quality of life in cancer patients”; “Long-term income and employment outcomes in cancer-survivors”, and “Phase-specific and lifetime costs of cancer in British Columbia and Ontario”. The objective of the first project is to evaluate the reliability and validity of cancer-specific measures of health related-quality of life in patients with cancer in BC. The objective of the second project is to estimate the effect of socio-demographic and clinical factors on cancer survivors’ income, and their ability to participate in the labor force using cross-sectional and longitudinal models; and the objective of the last project is to estimate costs for eighteen most common types of cancer in British Columbia. Over the course of his academic career, Dr. Teckle has published a number of scientific papers.

Katarzyna Kolasa has more than 16 years of working experience in the healthcare sector, with 10 years with the pharmaceutical and medical devices industry and six with the public payer. In the past, she worked at both global and regional HEOR functions at AstraZeneca and BiogenIdec being based in Sweden and Switzerland respectively. At Bristol Myers Squibb and Lunbeck she was leading Market Access teams in CEE and Nordic Region. Her practical skills in the field of health economics were developed during six years employment contract at the Kalmar County Council in Sweden. Since 2015, she has been working with pricing &reimbursement challenges in the field of medical devices. Currently being Global Market Access Principal Consultant for Straub Medical. Before that, Katarzyna was a Senior HEOR Director at GE Healthcare.

Dr. Elder is a visiting professor at King’s College, London; a member of the British Pharmacopoeia (BP) and the Editorial Advisory Board for the Journal of Pharmaceutical Sciences. He has published over 130 papers and presented over 130 presentations at international symposia. He has co- edited two books: “Analytical Characterization and Separation of Oligonucleotides and their Impurities” and “ICH Quality Guidelines”.

Dr Suhail Chughtai is a UK based Orthopaedic Surgeon and Medico.legal Examiner. Apart from being an experienced medical professional with over 15 years of consultant level experience in Orthopaedic & Trauma surgery, he has been a Microsoft Certified Specialist since 2001. He has designed and instructed over 50 Medical IT courses in Pakistan, UK and Saudi Arabia since 2001. His main strength is designing Medical Projects with embedded Live Video embedded for doctors such as www.MedicalWebinars.online for Medical Training & www.WebClinic.online for doing Virtual Clinics. His medico -medico-legal firm in London won a business award in 2011 owing to his innovative design of Medical Reporting Software. Dr Chughtai developed a web based TV Station (TVapex) in 2012 backed up by a Video Production Firm (Apex Video Professionals) in London. Both of these projects helped him to develop Medical Solutions with embedded Live two-way Video, such as “Web Clinic” and “Medical Webinars".He has lately formed a Software Firm with special focus on creating “Live Video embedded Web Software Projects” for Medical and allied professional industries (www.WebBroadcastingServices.com, based in London, UK).

Danielle Riverin-Simard, Ph.D., is professor emeritus at Université Laval (Canada) and editorial member of many scientific journals. From 1989 to 1992, she was the founding scientific director of the Centre for Research in Career Development, and, from 1995 to 1998, a Council member of the Social Sciences and Humanities Council of Canada. She has contributed significantly to the field of adult vocational education and of career transitions, development and management, through the publication of books (Phases of Working lives; Careers and social classes; Career Transitions: choices and strategies; Work and Personality; Key roles in the revolution of work) and of more than 150 articles in peer review. Danielle Riverin-Simard’s work, well-known in Quebec, Canada and internationaly, has received many prestigious rewards. She continues her research in this area by working with senior business executives, public managers and career practitioners to improve the lifelong learning and the lives of workers in the knowledge economy. (www.fse.ulaval.ca/danielle.riverin-simard)

Mustafa Z. Younis is an internationally recognized scholar and an Expert of Global Health Financing & Public Health. He was a member of the Executive Committee of the International Society for Research of Healthcare Financial Management. Dr. Younis has authored and published over 200 articles, abstracts and presentations in refereed journals and meetings, and has presented at national and international conferences. Dr. Younis has administrative experience as Senior Advisor for the President at Zirve University, Turkey and as Chair of the Department of Health Policy and Management at Florida International University (FL, USA) where he led the accreditation efforts for the Healthcare Management Program. Dr. Younis has a history of playing visible roles on the editorial boards of journals as Chief Editor, Guest Editor and Editorial board member of leading journals such as IJMR, JHCF, Inquiry, JHHSA, JPBAFM Dr. Younis is a frequent speaker for both academic and professional audiences. His talks often feature his latest research and work in progress as well as cross-industry trends and strategy implications. He has provided workshops and presentation for wide organizations. His research and findings applied to for-profit, non-profit settings, and government. Dr. Younis has consulted with several organizations on Healthcare Finance, and Economics. Dr. Younis is often invited to speak about the challenges in the healthcare industry and other related topics to health economics, finance, and research. He has presented topics, such as, healthcare reform, ownership structure, profitability, unit cost, payment system and efficiency in management, at a variety of forums and conferences in United States, Europe, Asia and Middle East.

Marcela Perticara is a labor economics specializing in gender and inequality issues. Since 2002 she has hold a full time position at ILADES-Universidad Alberto Hurtado. She got her Ph.D. in Economics at Texas A&M University. Her areas of interest are development economics and impact evaluation methodologies. Most of her research is focused on gender disparities, childcare issues and inequality in education. She has presented his research at seminars and conferences both nationally and internationally. She has also served in several governmental advisory board/committees and academic grant and fellowship review boards.

Sarah Neville is the Director, Pricing at the Independent Hospital Pricing Authority (IHPA), and is responsible for delivering the National Efficient Price annually. Sarah’s background is in mathematics and statistics, holding a Ph.D. in statistics from the University of Wollongong. She was invited to present doctoral research at the University of Oxford in 2012. Sarah recently spent six weeks in remote Australia working with Miwatj Health Aboriginal Corporation developing better ways to communicate key health statistics to Indigenous Australians.

Dr. Ailawadhi has expertise in the field of plasma cell disorders, specifically multiple myeloma and focuses on clinical drug development as well as a special interest in secondary data analysis looking at outcome disparities and healthcare economics. He has accumulated vast experience in the area of disparities in healthcare utilization and outcomes by patient race and ethnicity and how the management, access and effects of therapeutic interventions may be different for various patient subgroups. Several of his research projects focusing on healthcare economics, cost-effectiveness and outcome disparities have been recognized in the form of presentations at national and international meetings as well as peer-reviewed publications.

Samath D. Dharmaratne is an Associate Professor and a Consultant Community Physician attached to the Department of Community Medicine, Faculty of Medicine, University of Peradeniya, Sri Lanka and has been in the permanent academic cadre for the past 22 years. Samath was a former Head of the Department, a former Public Health specialist in the World Bank, and a former postgraduate fellow in the University of Washington. He is a Senior Fellow of the Postgraduate Institute of Medicine, University of Colombo. He is a Board Director of the Consortium of Universities for Global Health and the Course Coordinator of the Diploma in Exercise and Sport Sciences, Faculty of Medicine.

Richeal M. Burns is a health economist specializing in economic evaluation alongside clinical trials and burden of illness studies. Richeal has been involved in a range of disease areas including Prostate Cancer, Blood Disorders, Inflammatory Bowel Disease, Childhood Behaviors and Cardiovascular Disease. Her interests include examining methodological concerns in measuring quality of life and the application of quality of life measurement in economic evaluation

Arun Kumar Aggarwal is MD in Community Medicine and postgraduate in Health & Hospital Administration. He is Professor in School of Public Health of premier tertiary care institute (PGIMER) at Chandigarh, North India. He has done WHO fellowship in Health Financing & Economics from Bangkok and World Bank online course on Basics of Health Economics.

Sushil Ranjan Howlader was Professor and Director of the Department of Economics of University of Dhaka from 1995 1998 and thereafter became professor of the institute of health Economics of University of Dhaka, Dhaka. He was the founder Director of the Institute of Health Economics of University of Dhaka and worked as Director from 1998 to 2005 and again from 2007 to 2010 (July). He is also the former Director of the Bureau of Economic Research, University of Dhaka.He has carried out his doctoral study as a Winrock scholar on Development Economics at Jawaharlal Nehru University, New Delhi, in 1993.

Rafia Rahman works as Assistant Professor, Lecturer at Institute of Health Economics, University of Dhaka. She works with national and international NGOs for around nine years then an academician. Her wishes to increase, ensure health care services by registered trained provider in the countries. Rafia also has work experiences like, Training on “Norplant”, conducted by Mohammadpur Fertility Services & Training Center, Training on “No-Scalpel Vasectomy (NSV)” conducted by AITEM, Dhaka, Completed “Continuous Technology Update (CTU)” workshop organized by NSDP, Attended a training on “Integrated Management on Childhood Illness (IMCI)” at Dhaka Shishu Hospital, Attended a training on “Follow-up after IMCI Training”– at Ad din Hospital organized by NSDP, Completed “RTI/STI Management training” organized by NSDP, conducted by Radda MCH, “Quality Monitoring & Supervision of TB Program” workshop organized by URC, Supervision and performance evaluation of medical staff, Maintain liaison between the hospital and providing training to relevant medical and Skilled Birth Attendants (SBA), Developed an on-going training program for nursing and clinical staff, Provide Active Management of Third Stage of Labor (AMTSL) in four (04) districts of Bangladesh. She Attended 9th south East Asia Regional Scientific Meeting,” Epidemiology: A key to Achieve the Millennium development Goals” Workshop.

Professor Khalid’s is a clinical cardiologist by training, Professor Khalid previously served as the Dean of Universiti Teknologi MARA’s Faculty of Medicine. Under his stewardship, the faculty recorded tremendous growth and established itself as one of the foremost medical faculties in the nation. Prior to that, Professor Khalid played a number of key roles – including serving as Dean – in a career spanning two decades at Universiti Kebangsaan Malaysia. He also served as a consultant cardiologist at both universities where he was instrumental in developing the Heart Centres at these universities. Professor Khalid began his medical career as a student at The University of Melbourne, Australia. He was then trained in Cardiology at the University of Newcastle-upon-Tyne, UK. On returning to Malaysia, he built a strong career in academia, bolstered by national and international recognition of his contributions. He is a firm advocate of research and development and his findings are frequently published in high-impact international journals. His papers are cited and referred to by many of his peers, adding credence to his standing as an academic. What Professor Khalid brings to UCSI further enhances the University’s strong links with the industry and its vibrant student life. The latest addition to Professor Khalid’s ever expanding list of accolades and awards is a Doctor of Medical Sciences (honoris causa) conferred by his alma mater, The University of Melbourne, Australia in October 2014. The citation for the honorary doctorate by the Melbourne University’s Council identifies him as a person of distinguished eminence in medical science, research and effective medical education. His international outlook was best demonstrated in his development and forging of strategic partnerships between UCSI and world leading universities, culminating in UCSI’s proudest moment when our top Year 2 medical student was selected for an intercalated research year at Harvard University in the USA.

Dr. Teckle is a Health Economist at the Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency and an Assistant Professor in the School of Population and Public Health at the University of British Columbia. Previously he held positions at Health Economics Research Unit, University of Aberdeen UK. Whilst at the University of Aberdeen, Dr. Teckle was part of a research team that was commissioned by the Scottish Executive Health Department in 2005 to improve and refine the Arbuthnott Resources Allocation Formula used in Scotland. Since he joined the ARCC in 2006, Dr. Teckle has been working as a co-investigator in three projects: “Health-related quality of life in cancer patients”; “Long-term income and employment outcomes in cancer-survivors”, and “Phase-specific and lifetime costs of cancer in British Columbia and Ontario”. The objective of the first project is to evaluate the reliability and validity of cancer-specific measures of health related-quality of life in patients with cancer in BC. The objective of the second project is to estimate the effect of socio-demographic and clinical factors on cancer survivors’ income, and their ability to participate in the labor force using cross-sectional and longitudinal models; and the objective of the last project is to estimate costs for eighteen most common types of cancer in British Columbia. Over the course of his academic career, Dr. Teckle has published a number of scientific papers.

Katarzyna is a Market Access Director for Region East at Lundbeck. In the past, she worked for AstraZeneca, Bristol Myers Squibb as well as BiogenIdec leading Market Access teams in CEE Region. In total, she has been working for pharmaceutical industry for more than ten years now. The last six years she devoted mainly to Market Access for CEE Region. Her office is located in Finland. In the past she was based in Sweden and Switzerland. She holds a PhD degree in health economics and is an author of the number of publications in the field of health technology assessment and pharmacoeconomics. Katarzyna Kolasa has been invited to review manuscripts for Health Policy, Value in Health, Expert Review of Pharmacoeconomics & Outcomes Research and International Journal for Equity in Health. Her extensive knowledge in the field of health economics was acquired at University of York, University of Lund and University of Bergen as well as during International Doctoral Courses in Health Economics and Policy organized by the Swiss School of Public Health. Katarzyna Kolasa is DIA tutor for HTA courses, teacher at MBA in health program at Lazarski University, HTA training at Business School of Technical University in Warsaw and Adjunct at Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. In addition to her role as a University teacher, she lead Equity study as a part of InterQuality project organized by Warsaw Medical University, funded under the European Union\'s Seventh Framework Programme. She worked for World Bank regarding the hospital management project as well. Her practical skills in the field of health economics were developed during her six years employment contract at the Kalmar County Council in Sweden where she was responsible for a number of public health research programmes.

Carl Asche is the Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria, where he is a Research Professor both in the Departments of Medicine (Peoria) and Pharmacy Systems, Outcomes & Policy (Chicago). He is also a research affiliate with the University of Victoria Centre on Aging. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of being the author or co-author of over 75 papers appearing in the medical and economic literature. He is the editor of the forthcoming book entitled, “Applying Comparative Effectiveness Data to Medical Decision Making: A Practical Guide” (Adis, 2015). He has presented his research at seminars and conferences both nationally and internationally. He has served on numerous national and international health economics focused editorial, grant review, advisory boards and committees.Asche’s research is funded by a variety of state/federal agencies and health system providers.

Johannes Bircher has completed his professional formation at the University of Zürich, and his postgraduate education at the Mayo Clinic and the University of Zürich. Then he worked at the Department of Clinical Pharmacology of the University of Bern, at the Black Lion Hospital in Addis Ababa and at the University of Gottingen before he became dean of the Faculty of Medicine at the University of Witten/Herdecke. Now he is retired. He published 253 papers partly in high ranking scientific journals, and seven books.

Richard M. Scheffler is a Distinguished Professor of Health Economics and Public Policy at the School of Public Health and the Goldman School of Public Policy at the University of California, Berkeley. He also holds the Chair in Healthcare Markets & Consumer Welfare endowed by the Office of the Attorney General for the State of California. Professor Scheffler is the director of The Nicholas C. Petris Center on Health Care Markets and Consumer Welfare. He has been a Rockefeller and a Fulbright Scholar, and served as the President of the International Health Economists Association 4th Congress in 2004. Professor Scheffler has published about 200 papers and edited and written twelve books, including his most recent book, The ADHD Explosion: Myths, Medication, Money and Today's Push for Performance with Stephen Hinshaw, published by Oxford Press in March 2014, which was supported by a Robert Wood Johnson Investigator Award. He has conducted a recent review on Pay For Performance in Health for the World Health Organization and the OECD. He was awarded the Fulbright Scholarship at Pontifica Universidad Católica de Chile in in Santiago, Chile as well as the Chair of Excellence Award at the Carlos III University of Madrid in Madrid, Spain in 2012 through 2013. He was just awarded the Gold Medal from Charles University in Prague, Czech Republic for his continued support of international scientific and educational collaboration in 2015.

Extremely broad background in research, including many fields of medicine (wound care, evidence-based medicine, cost-effectiveness studies, epidemiology, ophthalmology, the study of pain, genetics, and burns, biochemistry, chemistry, and materials science), as well as decades of writing, editing, and publishing in these fields. Extensive experience in biostatistics, cost-effectiveness modeling, EBM study assessment (systematic reviews and meta-analysis) and clinical practice guideline creation, and designing clinical trial protocols. Experienced consultant with CMS and FDA. Extensive nutritional research and analysis. MEMBERSHIPS- APWCA (American Professional Wound Care Association) AAWC (Association for the Advancement of Wound Care) ACHM (American College of Hyperbaric Medicine) PAAO (Pan American Association for Ophthalmology

Dr. Sudip Chattopadhyay is the professor and past chairman of the Economics Department at San Francisco State University (SFSU). He obtained his Ph. D. in Economics in 1997 from University of Illinois at Urbana-Champaign. He has been on the SFSU Economics faculty since 1999. His research interest is in applying economic theories and models for economic evaluation of public policies, specifically in the areas of health and the environment. He has published in numerous peer-reviewed journals. His works have been extensively cited and some of them have been reprinted in special volumes for their enduring quality. Currently, Dr. Chattopadhyay is serving as an ORISE Fellow at the federal office of Health Resources and Services Administration (HRSA) to establish a research agenda focusing on healthcare workforce.

Martin Kowarsch heads the working group ‘Scientific Assessments, Ethics, and Public Policy’ (SEP) at the Mercator Research Institute on Global Commons and Climate Change (MCC) Berlin. SEP does research on integrated scientific assessment-making in the context of (environmental) public policy processes, and focuses in particular on the appropriate treatment of, and ethical reflection on, normative issues and multiple stakes therein. Kowarsch is coordinator of a research initiative by MCC jointly with the United Nations Environment Programme (UNEP) on ‘the Future of Global Environmental Assessment Making’.

• Design of integrated scientific assessments, particularly environmental assessments • Normative and theoretical models of scientific expertise in public policy • Ethical issues at the science-policy interface, and the co-production of knowledge • Deweyan pragmatist ethics of land use policy and the global commons

Dr Jan Baekelandt qualified as a Medical Doctor (1999) and specialist in Gynaecology and Obstetrics (2004) at the Catholic University of Leuven, Belgium. He subspecialized as gynaecological oncologist (2004-2006) in Pretoria (South Africa) and Köln (Germany). He currently consults at Imelda Hospital (Bonheiden, Belgium), specializing in gynaecological oncology, and robotic and endoscopic surgery. He is a pioneer in the emerging field of Natural Orifice Surgery and has published multiple papers on transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES). He was first to introduce transvaginal robotic surgery

Umberto Petruccelli is Professor at the School of Engineering of the University of Basilicata (Potenza - Italy) since 2001, formerly Assistant Professor (1986-2001), where he holds the courses of "Transport techniques and economics" and "Urban and metropolitan transport". He worked, as well as research manager, in inter-university national and international research programs and also in research agreements with public institutions aimed at the study of relevant transportation issues. He published many scientific papers on the Italian and international literature. His recent research activity has focused on mobility analysis and planning, with special regard to the quality and the standard cost of transit services, the impact and cost of transport externalities, the management of the urban road system and the safety of the transport system ordinary and disable users.

Dr. Carl Asche is the Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria, where he is a Research Professor both in the Departments of Medicine (Peoria) and Pharmacy Systems, Outcomes & Policy (Chicago). He is also a research affiliate with the University of Victoria Centre on Aging. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of being the author or co-author of over 75 papers appearing in the medical and economic literature. He is the editor of the forthcoming book entitled, “Applying Comparative Effectiveness Data to Medical Decision Making: A Practical Guide” (Adis, 2015). He has presented his research at seminars and conferences both nationally and internationally. He has served on numerous national and international health economics focused editorial, grant review, advisory boards and committees. Dr. Asche’s research is funded by a variety of state/federal agencies and health system providers.

-

Katarzyna is a Market Access Director for Region East at Lundbeck. In the past, she worked for AstraZeneca, Bristol Myers Squibb as well as BiogenIdec leading Market Access teams in CEE Region. In total, she has been working for pharmaceutical industry for more than ten years now. The last six years she devoted mainly to Market Access for CEE Region. Her office is located in Finland. In the past she was based in Sweden and Switzerland. She holds a PhD degree in health economics and is an author of the number of publications in the field of health technology assessment and pharmacoeconomics. Katarzyna Kolasa has been invited to review manuscripts for Health Policy, Value in Health, Expert Review of Pharmacoeconomics & Outcomes Research and International Journal for Equity in Health. Her extensive knowledge in the field of health economics was acquired at University of York, University of Lund and University of Bergen as well as during International Doctoral Courses in Health Economics and Policy organized by the Swiss School of Public Health. Katarzyna Kolasa is DIA tutor for HTA courses, teacher at MBA in health program at Lazarski University, HTA training at Business School of Technical University in Warsaw and Adjunct at Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. In addition to her role as a University teacher, she lead Equity study as a part of InterQuality project organized by Warsaw Medical University, funded under the European Union\'s Seventh Framework Programme. She worked for World Bank regarding the hospital management project as well. Her practical skills in the field of health economics were developed during her six years employment contract at the Kalmar County Council in Sweden where she was responsible for a number of public health research programmes.

Dr. Teckle is a Health Economist at the Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency and an Assistant Professor in the School of Population and Public Health at the University of British Columbia. Previously he held positions at Health Economics Research Unit, University of Aberdeen UK. Whilst at the University of Aberdeen, Dr. Teckle was part of a research team that was commissioned by the Scottish Executive Health Department in 2005 to improve and refine the Arbuthnott Resources Allocation Formula used in Scotland. Since he joined the ARCC in 2006, Dr. Teckle has been working as a co-investigator in three projects: “Health-related quality of life in cancer patients”; “Long-term income and employment outcomes in cancer-survivors”, and “Phase-specific and lifetime costs of cancer in British Columbia and Ontario”. The objective of the first project is to evaluate the reliability and validity of cancer-specific measures of health related-quality of life in patients with cancer in BC. The objective of the second project is to estimate the effect of socio-demographic and clinical factors on cancer survivors’ income, and their ability to participate in the labor force using cross-sectional and longitudinal models; and the objective of the last project is to estimate costs for eighteen most common types of cancer in British Columbia. Over the course of his academic career, Dr. Teckle has published a number of scientific papers.

-

Professor Khalid’s is a clinical cardiologist by training, Professor Khalid previously served as the Dean of Universiti Teknologi MARA’s Faculty of Medicine. Under his stewardship, the faculty recorded tremendous growth and established itself as one of the foremost medical faculties in the nation. Prior to that, Professor Khalid played a number of key roles – including serving as Dean – in a career spanning two decades at Universiti Kebangsaan Malaysia. He also served as a consultant cardiologist at both universities where he was instrumental in developing the Heart Centres at these universities. Professor Khalid began his medical career as a student at The University of Melbourne, Australia. He was then trained in Cardiology at the University of Newcastle-upon-Tyne, UK. On returning to Malaysia, he built a strong career in academia, bolstered by national and international recognition of his contributions. He is a firm advocate of research and development and his findings are frequently published in high-impact international journals. His papers are cited and referred to by many of his peers, adding credence to his standing as an academic. What Professor Khalid brings to UCSI further enhances the University’s strong links with the industry and its vibrant student life. The latest addition to Professor Khalid’s ever expanding list of accolades and awards is a Doctor of Medical Sciences (honoris causa) conferred by his alma mater, The University of Melbourne, Australia in October 2014. The citation for the honorary doctorate by the Melbourne University’s Council identifies him as a person of distinguished eminence in medical science, research and effective medical education. His international outlook was best demonstrated in his development and forging of strategic partnerships between UCSI and world leading universities, culminating in UCSI’s proudest moment when our top Year 2 medical student was selected for an intercalated research year at Harvard University in the USA.

Guy H Fontaine MD PhD HDR has made 15 original contributions in the design and the use of the first cardiac pace makers in the early 60s. He has serendipitously identified ARVD during antiarrhythmic surgery in the early 70s. He has developed the technique of Fulguration to replace surgery in the early 80s. He has been one of the 216 individuals who have made a significant contribution to the study of cardiovascular disease since the 14th century and one of the 500 greatest geniuses of the 21st Century (USA Books), one of the 100 life time of achievement (UK Book). He has > 900 publications including 201 book chapters. He is a reviewer of 17 scientific journals both in basic and clinical science. He has given 11 master lectures of 90 minutes each in inland China in 2014. He is now developing new techniques for brain protection in OHCA, stroke and spinal cord injury by hypothermia.

Cardiomyopathies, Right Ventricular Dysfunction, cardiac imaging, myocarditis.

Jean Caron, PhD, studies the mental health of populations, focusing primarily on:the epidemiology of mental disorders and suicide the assessment of mental health services the validation of psychometric instruments His initial collaboration with the Douglas Mental Health University Institute was in 1993 when he was a professor in the Department of Human and Social Developmentat the Université du Québec en Abitibi-Témiscamingue. He joined the Psychosocial Research Division in 1998 and subsequently became an Associate Professor of Psychiatry at McGill University. He currently leads the Canadian Institutes of Health Research Team in Social and Psychiatric Epidemiology. He is also an associate researcher at the Institut de Santé publique of the Université de Montréal and the Instituto de Saude Colletiva of the Federal University of Bahia in Brazil.His recent studies have identified determinants of psychological distress and quality of life among different populations: the general population, low-income populations and populations with mental health problems. He has focused particularly on social support as a protective factor in mental health.Jean Caron’s research has received national and international recognition. He was a visiting scientist at the Mental Health Institute of the Andalusian Ministry of Health and avisiting professor in the Department of Social Psychology at the University of Seville, in Spain. He is a consultant in social and psychiatric epidemiology to the Public Health Agency of Canada, Statistics Canada, the Quebec Department of Public Health, and the U.S. National Institutes of Health.

Epidemiology

David J Galton is Emeritus Professor at London University. He gained doctorates in Medicine (M.D. for work done in the USA) and in Science (D.Sc.). He has published 8 books, and more than 250 research papers on genetics of common metabolic disorders; nine students from his laboratory have become Professors. He served as consultant physician to St. Bartholomew’s Hospital and Moorfield’s Eye Hospital, London. David J Galton has served in various senior positions as the former Chairman of Clinical Science U.K, Chairman of HEART UK and Secretary to the European Atherosclerosis Society. He is an elected Fellow of 2 Royal Colleges, the Physicians (FRCP) and Ophthalmologists (FRCOphth).

Metabolic regulation, SNP analysis, genetics of lipid disorders, atherosclerosis.

Young graduated from the Johns Hopkins Bloomberg School of Public Health as Master and Doctor of Public Health, with specialization in Epidemiology and Social Medicine. He also took a Master’s degree in Sociology from Pennsylvania State University where he studied demography, biostatistics and quantitative research methods as a doctoral candidate. His research focuses on the distribution of air toxic exposure, neighborhood health effects, and vulnerability to chronic disease and health care disparities. He holds positions as Executive Vice President for Health Policy at Cooper University Health Care and Assistant Professor in the Department of Medicine of Cooper Medical School of Rowan University, where he is Director of the Center for Injury Epidemiology and Social Medicine.

Epidemiology,Medicine

Wolfgang Seger was a doctor of medicine at the Freie Universität Berlin in 1977 and received his license as a physician in 1978. Afterwards, he was initially a research assistant at the Institute of Clinical Radiology at Hanover Medical University. After working at various clinics, he opened his main practice in internal medicine / gastroenterology in Bad Pyrmont in 1985 and was a consultant for the operative therapy of two clinics. From 1989 to 1991, Seger was a senior physician at the Lorch Social Medicine Clinic, and until 1994 he was the senior physician of the Social Medicine Department of the LVA Oldenburg-Bremen. In 1994 Seger became a senior physician of the medical service of the health insurance of Lower Saxony (MDKN) and in 1997 his deputy managing director. In 1998 the University of Bremen was appointed honorary professor for rehabilitation medicine.

Rehabilitation and Social Medicine

Sophia Salenius is Managing Director of RegPoint Ltd, a health services company supplying wireless technology to the global healthcare community. She is a leading expert in the international IT healthcare field and a sought after guest speaker at professional conferences around the world. Ms. Salenius is well known as the inventor behind the unique mHealth solution for public health threat detection and management called RegPoint. Her invention is also used in a wireless early warning and advice solution for natural disasters such as earthquakes, tsunamis and hurricanes, as well as to combat public health threats including chronic diseases and epidemics such as SARS and the Avian A flu.

Epidemic

In 2001 Cristina Stasi graduated in Medicine and Surgery at the Catholic University of “Sacro Cuore”, Rome. In 2006 she specialized in Gastroenterology at the University of Pisa. From 2006 to 2009 she took part in clinical research projects at the University Hospital “Careggi”, Florence. At the same time she improved her knowledge in Study Design, Management of Clinical Research Project, Statistics, Epidemiology. In 2013 she received her PhD in Experimental and Clinical Medicine from the University of Florence. She published more than 40 papers in reputed international journals and she has been serving as an editorial board member of some international journals.

Epidemiology

Ahmad M. Khalil received Ph.D. from the Ohio State University in 1987. Currently is a Professor at Yarmouk University, Irbid, JORDAN. Earned the professorship in 2000. Director of the Department of Biological Sciences at Yarmouk 2001-2003. Founded the Biotechnology M. Sc. Program at Yarmouk in 2003. In Arabic, authored a book in Radiation Biology, a unit in Molecular Biology, a chapter in Genetics and 35 articles of general interest. Published 40 research papers most of them in International Journals. Developed expertise in investigating the biology of prostate cancer in collaboration with King Abduallah Hospital at Jordan University of Science and Technology (JUST).

Epidemiology, Public Health

Dr. Roberto Antonio Flores has been Graduated from National University of Tucuman, Argentina as Medical Doctor, with the specialties including Internal Medicine, Social and Community Medicine and Diploma in Cardiology from the National University of Tucuman and Medical Clinic National Academy of Medicine Argentina. Later on he obtained his post-graduation from National University of Cuyo with subjects Pharmacology & Biology and then started working at The Nurses School, Faculty of Humanities, Social Sciences and Health, National University of Santiago del Estero, Argentina where he has continued his research. Presently he has been working at the at the Regional Hospital Dr. Ramon Carrillo, Santiago del Estero City. He has got eminent memberships in many Scientific Societies including Internal Medicine and Cardiology at the Society of Santiago del Estero, Argentina, Membership of Argentina Federation of Cardiology, Membership of Hypertension Committee of Argentina Federation of Cardiology, Membership of Inter American Society of Cardiology and Board of Epidemiology of Inter American Society of Cardiology

Epidemiology

Amir Baigi has 28 years experiences in health surveys, evaluation and expertise in improving the health and wellbeing.His scientific network extend from Gothenburg University in west to Lund University in south of Sweden.

Epidemiology

Syamantak Mani Tripathi is an Assistant Professor in the Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Chhattisharh Kamdhenu Vishwavidalya, Durg-491001 (Chhattisgarh) India. He has over six years experience with hand-on applications including teams of researchers and technicians in the Pharmacology & Toxicology and Biotechnology division. His training and experience also includes applied animal investigation skills as a research scholar in the field of pesticide induced immunotoxicology and safety pharmacology studies. He has worked in multiple successful research projects funded by Indian Council of Agricultural Research and Department of Biotechnology, Government of India, supporting clinical development and leading to strong regulatory submissions for pesticides uses in agriculture. His research program is focused on the study of immune response to pesticide and xenobiotics in avian model. He received his Bachelor’s in Veterinary Science and Animal Husbandry from Jawaharlal Nehru Krishi Vishwavidyalaya, Jabalpur (MP), India; Master’s of Veterinary Pharmacology from Anand Agricultural University, Anand (Gujarat), India and his Ph.D. in Veterinary Pharmacology and Toxicology from the Nanaji Deshmukh Veterinary Science University at Jabalpur (MP), India. His academic work was focused on “Immuno-genotoxicity of organophosphorous insecticide ‘acephate’ in white leghorn birds”. His work contributes towards understanding the molecular mechanism of acephate toxicity in avian model; studying interleukin gene(s) associated with immunity and development of test series to study immunotoxicity. Memberships he has include the Indian Society of Toxicology, Indian Society of Veterinary Pharmacology and Toxicology.

Epidemiology,Toxicology